BIB is a contract development and manufacturing organization (CDMO) that caters to clients in both the mammalian and microbial sectors. Positioned as a full spectrum service provider, BIB offers preclinival development services, clinical development services, and commercial manufacturing services for large molecule as well as gene and cell therapy-based pharmaceuticals. The company was established in 2015 and has headquarters in Southborough, MA, which lies within the metro-Boston area, also known as the Genetown Hotbed. Although young, this company's core team is composed of seasoned scientists that have worked at some of the world's most paramount CMOs and that hold 20+ years of experience within the CDMO arena. BIB maintains a close relationship with Cambridge's top tier universities, including MIT. The company strives to integrate cutting-edge technology into its laboratories, shortening clients' projects' timelines while delivering quality and budget-friendly solutions.